← Back to the full profile

Prepare for your visit

Esther Patsy Mihindu

Vascular Surgery · Dallas, TX · NPI 1104116136

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$9,303.78

in general payments reported to CMS, 2019-2025 · $1,411 in 2025

The $1,411 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Who reported paying

General payments only, top 6 by amount.

Drugs and devices associated with these payments

Dayspring Koya Medical Serrantor Ranger (4067) Tack Endovascular Systems Btk (6536) Phoenix Kerecis Omega3 Surgiclose (9282) Turbo Power Jeti Peripheral Catheter Angiojet Ultra 5000a Alto Abdominal Stent Graft System Flexitouch Plus

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1384128/esther-patsy-mihindu